Agilon Health, Inc. (AGL) is a Medical - Care Facilities company in the Healthcare sector, currently trading at $22.68. It has a SharesGrow Score of 31/100, indicating a weak investment profile with 1 out of 7 criteria passed.
Analyst consensus target is AGL = $4 (-84.5% upside).
Valuation: AGL trades at a trailing Price-to-Earnings (P/E) of -0.7 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.03.
Financials: revenue is $5.9B, +32.6%/yr average growth. Net income is $405M (loss), growing at -66.9%/yr. Net profit margin is -6.8% (negative). Gross margin is -3.2% (-7.3 pp trend).
Balance sheet: total debt is $37M against $127M equity (Debt-to-Equity (D/E) ratio 0.29, conservative). Current ratio is 1.02 (adequate). Debt-to-assets is 2.9%. Total assets: $1.3B.
Analyst outlook: 6 / 25 analysts rate AGL as buy (24%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 72/100 (Pass), Growth 58/100 (Partial), Past 0/100 (Fail), Health 50/100 (Partial), Moat 12/100 (Fail), Future 16/100 (Fail), Income 10/100 (Fail).
